Drug profile · INN
linagliptin + metformin
TRAJENTAMET
linagliptin + metformin (TRAJENTAMET) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
TGA: approved
Patents linked 0
Pipeline programs 3
News articles 0
Drug details — linagliptin + metformin
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 3
- Data quality
- 0.81
Quick answer
linagliptin + metformin (TRAJENTAMET) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is linagliptin + metformin?
linagliptin + metformin (TRAJENTAMET) is an FDA-listed pharmaceutical active ingredient. Associated with Boehringer Ingelheim Pty Ltd.
What is the brand name for linagliptin + metformin?
TRAJENTAMET is a marketed brand name for linagliptin + metformin. Check FDA Drugs@FDA for the current US label holder and prescribing information.